These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32419008)

  • 21. Neurologic approach to drug-induced movement disorders: a study of 125 patients.
    Miller LG; Jankovic J
    South Med J; 1990 May; 83(5):525-32. PubMed ID: 1971459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of low-dose amitriptyline on globus pharyngeus and its side effects.
    You LQ; Liu J; Jia L; Jiang SM; Wang GQ
    World J Gastroenterol; 2013 Nov; 19(42):7455-60. PubMed ID: 24259978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study.
    Dale RC; Grattan-Smith P; Nicholson M; Peters GB
    Dev Med Child Neurol; 2012 Jul; 54(7):618-23. PubMed ID: 22515636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrapyramidal symptoms with concomitant use of amitriptyline and amiodarone in an elderly patient.
    Pawar PS; Woo DA
    Am J Geriatr Pharmacother; 2010 Dec; 8(6):595-8. PubMed ID: 21356508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine-associated movement disorders: A literature review.
    Rissardo JP; Caprara ALF
    Tzu Chi Med J; 2020; 32(4):318-330. PubMed ID: 33163376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin-associated movement disorder: A literature review.
    Rissardo JP; Caprara ALF
    Tzu Chi Med J; 2022; 34(4):409-417. PubMed ID: 36578637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Movement disorders and stroke.
    Defebvre L; Krystkowiak P
    Rev Neurol (Paris); 2016; 172(8-9):483-487. PubMed ID: 27476417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal teratogenicity in a rhesus macaque (Macaca mulatta): Association with the chronic maternal treatment of amitriptyline.
    Hunter CE; Stammen RL; Hamlet T; Bonenberger D; Li C; Zhang X; Stroud FC; Chan AWS
    J Med Primatol; 2021 Feb; 50(1):75-78. PubMed ID: 33277721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of Movement Disorders in two Movement Disorders Centers in the Philippines.
    Yu JRT; Jamora RDG; Silverio EL; Bautista JMP; Luspian KJL; Tiongson RM; Ng AR
    Acta Neurol Taiwan; 2021 Sep; 30(3)():94-101. PubMed ID: 34841504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of acute movement disorders in children.
    Dale RC; Singh H; Troedson C; Pillai S; Gaikiwari S; Kozlowska K
    Dev Med Child Neurol; 2010 Aug; 52(8):739-48. PubMed ID: 20163436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperkinetic movement disorders.
    Bressman SB; Greene PE
    Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and subacute drug-induced movement disorders.
    Burkhard PR
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S108-12. PubMed ID: 24262159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of restless legs syndrome in functional movement disorders: a case-control study from the Czech Republic.
    Serranová T; Slovák M; Kemlink D; Šonka K; Hallett M; Růžička E
    BMJ Open; 2019 Jan; 9(1):e024236. PubMed ID: 30670516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypersensitivity syndrome caused by amitriptyline administration.
    Milionis HJ; Skopelitou A; Elisaf MS
    Postgrad Med J; 2000 Jun; 76(896):361-3. PubMed ID: 10824052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of amitriptyline on risperidone pharmacokinetics in schizophrenic patients.
    Sommers DK; Snyman JR; van Wyk M; Blom MW; Huang ML; Levron JC
    Int Clin Psychopharmacol; 1997 May; 12(3):141-5. PubMed ID: 9248870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonus and movement disorders.
    Vercueil L
    Neurophysiol Clin; 2006; 36(5-6):327-31. PubMed ID: 17336777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tricyclic antidepressant-induced extrapyramidal side effects.
    Vandel P; Bonin B; Leveque E; Sechter D; Bizouard P
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):207-12. PubMed ID: 9213080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary position upbeat nystagmus associated with amitriptyline use.
    Osborne SF; Vivian AJ
    Eye (Lond); 2004 Jan; 18(1):106. PubMed ID: 14707989
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and biochemical footprints of inherited metabolic diseases. I. Movement disorders.
    Ferreira CR; Hoffmann GF; Blau N
    Mol Genet Metab; 2019 May; 127(1):28-30. PubMed ID: 30928149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.